Alzheimer's News

Monday, July 10, 2006

Athenagen and Zapaq to Merge: Financial News - Yahoo! Finance

Athenagen and Zapaq to Merge: "- Athenagen, Inc. and Zapaq, Inc., both privately held biopharmaceutical companies, said today that they have signed a letter of intent to merge the two companies. The companies both have leading programs focused on neurological diseases, including several proprietary compounds targeting Alzheimer's disease. The merger is expected to be completed before the end of August."

0 Comments:

Post a Comment

<< Home